Search research articles
Contact Us
Filters
Showing results (11-20 of 64) with videos related to
Page
of 7
Sort By:
Annales De Biologie Clinique
|
October 12, 2013
[Method validation according to ISO 15189 and SH GTA 04: application for the extraction of DNA and its quantitative evaluation by a spectrophotometric assay]
Alexandre Harlé, Maëva Lion, Marie Husson, et al.
International Journal of Molecular Sciences
|
May 21, 2020
SMAD4 and the TGFβ Pathway in Patients with Pancreatic Ductal Adenocarcinoma
Julie Dardare, Andréa Witz, Jean-Louis Merlin, et al.
Scientific Reports
|
October 12, 2019
Somatic substitution signature as an innovative tool in lung cancer diagnosis
Stéphane Busca, Julia Salleron, Romain Boidot, et al.
Oncology Letters
|
September 8, 2016
Trastuzumab as a preoperative monotherapy does not inhibit HER2 downstream signaling in HER2-positive breast cancer
Maëva Lion, Alexandre Harlé, Julia Salleron, et al.
International Journal of Molecular Sciences
|
October 23, 2019
Emerging Roles of DDB2 in Cancer
Pauline Gilson, Guillaume Drouot, Andréa Witz, et al.
Clinical and Experimental Medicine
|
January 17, 2024
Tumor-derived cell-free DNA and circulating tumor cells: partners or rivals in metastasis formation?
Andréa Witz, Julie Dardare, Margaux Betz, et al.
Archives of Medical Research
|
November 12, 2018
Clinical Interest of Circulating Tumor DNA in Oncology
Claire Franczak, Pierre Filhine-Tressarieu, Julien Broséus, et al.
Expert Review of Molecular Diagnostics
|
January 17, 2019
Technical considerations for circulating tumor DNA detection in oncology
Claire Franczak, Pierre Filhine-Tresarrieu, Pauline Gilson, et al.
Oncology Reports
|
January 15, 2013
Analysis of PIK3CA exon 9 and 20 mutations in breast cancers using PCR-HRM and PCR-ARMS: correlation with clinicopathological criteria
Alexandre Harlé, Maëva Lion, Nicolas Lozano, et al.
International Journal of Surgery (London, England)
|
August 10, 2016
Limited effectiveness of patent blue dye in addition to isotope scanning for identification of sentinel lymph nodes: Cross-sectional real-life study in 1024 breast cancer patients
Philippe Rauch, Jean-Louis Merlin, Lea Leufflen, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 64) with videos related to
Sort By:
Page
of 7
Annales De Biologie Clinique
|
October 12, 2013
[Method validation according to ISO 15189 and SH GTA 04: application for the extraction of DNA and its quantitative evaluation by a spectrophotometric assay]
Alexandre Harlé, Maëva Lion, Marie Husson, et al.
International Journal of Molecular Sciences
|
May 21, 2020
SMAD4 and the TGFβ Pathway in Patients with Pancreatic Ductal Adenocarcinoma
Julie Dardare, Andréa Witz, Jean-Louis Merlin, et al.
Scientific Reports
|
October 12, 2019
Somatic substitution signature as an innovative tool in lung cancer diagnosis
Stéphane Busca, Julia Salleron, Romain Boidot, et al.
Oncology Letters
|
September 8, 2016
Trastuzumab as a preoperative monotherapy does not inhibit HER2 downstream signaling in HER2-positive breast cancer
Maëva Lion, Alexandre Harlé, Julia Salleron, et al.
International Journal of Molecular Sciences
|
October 23, 2019
Emerging Roles of DDB2 in Cancer
Pauline Gilson, Guillaume Drouot, Andréa Witz, et al.
Clinical and Experimental Medicine
|
January 17, 2024
Tumor-derived cell-free DNA and circulating tumor cells: partners or rivals in metastasis formation?
Andréa Witz, Julie Dardare, Margaux Betz, et al.
Archives of Medical Research
|
November 12, 2018
Clinical Interest of Circulating Tumor DNA in Oncology
Claire Franczak, Pierre Filhine-Tressarieu, Julien Broséus, et al.
Expert Review of Molecular Diagnostics
|
January 17, 2019
Technical considerations for circulating tumor DNA detection in oncology
Claire Franczak, Pierre Filhine-Tresarrieu, Pauline Gilson, et al.
Oncology Reports
|
January 15, 2013
Analysis of PIK3CA exon 9 and 20 mutations in breast cancers using PCR-HRM and PCR-ARMS: correlation with clinicopathological criteria
Alexandre Harlé, Maëva Lion, Nicolas Lozano, et al.
International Journal of Surgery (London, England)
|
August 10, 2016
Limited effectiveness of patent blue dye in addition to isotope scanning for identification of sentinel lymph nodes: Cross-sectional real-life study in 1024 breast cancer patients
Philippe Rauch, Jean-Louis Merlin, Lea Leufflen, et al.
Page
of 7